Flow Traders U.S. LLC Novartis Ag Transaction History

Flow Traders U.S. LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$92.57 - $107.37 $1.27 Million - $1.47 Million	13,726 New	13,726 $1.46 Million
Q1 2021 May 17, 2021	SELL	$83.5 - $98.47 $625,999 - $738,229	-7,497 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$78.07 - $94.43 $585,290 - $707,941	7,497 New	7,497 $708,000
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $204,611 - $225,469	-2,392 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $149,669 - $184,208	-1,985 Reduced 45.35%	2,392 $218,000
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $329,675 - $377,078	4,377 New	4,377 $421,000
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $291,122 - $336,743	-4,349 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $282,293 - $319,042	4,349 New	4,349 $329,000

1,423

130M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $215B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Flow Traders U.S. LLC, based on Form 13F filings with the SEC.

Stay updated on Flow Traders U.S. LLC with notifications on news.